D-Wave Quantum Inc.

New York Stock Exchange
Back to all articles
Bullish +65

D-Wave Quantum (QBTS) And Rigetti (RGTI) Each Land $100M In Federal ...

AI-generated analysis

🚀 D-Wave Quantum (QBTS) secured up to $100 million in federal funding via the CHIPS and Science Act, granting the Department of Commerce a minority stake without operational control.

💼 The company enters this funding arrangement from a commercially advanced position with existing customers, production applications, and a growing cloud business generating real-world revenue.

📈 D-Wave reported a large increase in bookings and a rapidly expanding sales pipeline, offering an immediate path to converting federal dollars into measurable business outcomes.

⚠️ Despite the funding boost, D-Wave remains deeply unprofitable with adjusted EBITDA losses widening to $37.1 million in the most recent second quarter compared to $20 million a year ago.

📉 The stock is characterized as a high-risk, long-term position best suited for investors with a tolerance for very high volatility within the early-stage quantum sector.

👍 Wall Street analysts are broadly bullish on QBTS, with 14 of 17 covering firms rating it 'Strong Buy' or 'Moderate Buy' and only two advising a 'Hold'.

🎯 The consensus average price target of $34.81 implies potential upside of approximately 105% from current levels over the next 12 months.

💰 The most optimistic analyst price target sits at $43, pointing to a potential upside of 153% for investors willing to hold through sector uncertainty.

Bullish Signals
  • D-Wave secured up to $100 million in federal funding via the CHIPS and Science Act, providing critical runway without operational control constraints.
  • The company possesses a commercially advanced position with existing customers, production applications, and a growing cloud business already generating real-world revenue.
  • D-Wave reported a large increase in bookings and a rapidly expanding sales pipeline, giving it an immediate path to converting federal dollars into measurable business outcomes.
  • Wall Street analysts are broadly bullish on the stock, with 14 of 17 covering firms rating it 'Strong Buy' or 'Moderate Buy'.
  • The consensus average price target of $34.81 implies potential upside of approximately 105% from current levels over the next 12 months.
Risk Factors
  • D-Wave remains deeply unprofitable, with adjusted EBITDA losses widening to $37.1 million in the most recent second quarter compared to $20 million a year ago.
  • The stock is characterized as a high-risk, long-term position best suited for investors with a tolerance for very high volatility.
Full Analysis
D-Wave Quantum (QBTS) has secured up to $100 million in funding through the CHIPS and Science Act, a deal that grants the Department of Commerce a minority ownership stake without operational control. This capital infusion provides critical runway for the company as it navigates a capital-intensive, pre-profit industry phase. Unlike its peer Rigetti, which plans to use funds for foundational scaling, D-Wave enters this arrangement with a commercially advanced position featuring existing customers, production applications, and a growing cloud business generating real-world revenue. The company has reported a significant increase in bookings and an expanding sales pipeline, positioning it to convert federal dollars into measurable business outcomes more immediately than competitors. Despite the strategic advantages provided by the funding and strong analyst sentiment, D-Wave remains deeply unprofitable. In its most recent second quarter, the company's adjusted EBITDA loss widened to $37.1 million from $20 million in the prior year period. Consequently, investors view QBTS as a high-risk, long-term position characterized by very high volatility. Wall Street analysts remain broadly bullish on D-Wave, with 14 of 17 covering firms rating it a 'Strong Buy' or 'Moderate Buy.' The consensus average price target of $34.81 implies potential upside of approximately 105% from current levels over the next 12 months, while the most optimistic target reaches $43.